These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 12777748)

  • 21. Decrease in RelA phosphorylation by inhibiting protein kinase A induces cell death in NF-kappaB-expressing and drug-resistant tumor cells.
    Manna SK; Gangadharan C
    Mol Immunol; 2009 Apr; 46(7):1340-50. PubMed ID: 19128834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression.
    Zhang HM; Yuan J; Cheung P; Chau D; Wong BW; McManus BM; Yang D
    Mol Cell Biol; 2005 Jul; 25(14):6247-58. PubMed ID: 15988033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
    Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis.
    Liu J; Zhan M; Hannay JA; Das P; Bolshakov SV; Kotilingam D; Yu D; Lazar AF; Pollock RE; Lev D
    Mol Cancer Res; 2006 Nov; 4(11):803-10. PubMed ID: 17077165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A high constitutive level of NF-kappa B is necessary for viability of murine adenocarcinoma cells--possible role of p53].
    Smirnov AS; Budanov AV; Ruzov AS; Ivanov AV; Prokhorchuk AV; Gnuchev NV; Prokhorchuk EB
    Mol Biol (Mosk); 2000; 34(5):775-82. PubMed ID: 11033801
    [No Abstract]   [Full Text] [Related]  

  • 26. Tumour cell death.
    Bowen ID; Amin F
    Symp Soc Exp Biol; 2000; 52():253-64. PubMed ID: 12090013
    [No Abstract]   [Full Text] [Related]  

  • 27. NFκB and p53: A life and death affair.
    Oren M; Cooks T
    Cell Cycle; 2010 Mar; 9(6):1027. PubMed ID: 20237416
    [No Abstract]   [Full Text] [Related]  

  • 28. Ferroptosis in p53-dependent oncosuppression and organismal homeostasis.
    Galluzzi L; Bravo-San Pedro JM; Kroemer G
    Cell Death Differ; 2015 Aug; 22(8):1237-8. PubMed ID: 26143748
    [No Abstract]   [Full Text] [Related]  

  • 29. Gene expression changes as potential biomarkers of tumour bearing status in humans.
    Ember I; Kiss I; Faluhelyi Z
    Eur J Cancer Prev; 1998 Aug; 7(4):347-8. PubMed ID: 9806124
    [No Abstract]   [Full Text] [Related]  

  • 30. A new inflammatory role for p53 in human macrophages.
    Lowe JM; Menendez D; Fessler MB
    Cell Cycle; 2014; 13(19):2983-4. PubMed ID: 25486553
    [No Abstract]   [Full Text] [Related]  

  • 31. Why cancer and inflammation?
    Rakoff-Nahoum S
    Yale J Biol Med; 2006 Dec; 79(3-4):123-30. PubMed ID: 17940622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Report on the 5th Japanese-German Workshop on molecular and cellular aspects of carcinogenesis.
    Kuroki T; Rajwesky MF
    Int J Cancer; 1996 Mar; 66(1):1-5. PubMed ID: 8608950
    [No Abstract]   [Full Text] [Related]  

  • 33. Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation.
    Salla M; Guo J; Joshi H; Gordon M; Dooky H; Lai J; Capicio S; Armstrong H; Valcheva R; Dyck JRB; Thiesen A; Wine E; Dieleman LA; Baksh S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of nuclear factor-κB in the angiogenesis of glioma: Insights into the associated molecular mechanisms and targeted therapies.
    Tu J; Fang Y; Han D; Tan X; Jiang H; Gong X; Wang X; Hong W; Wei W
    Cell Prolif; 2021 Feb; 54(2):e12929. PubMed ID: 33300633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of nuclear factor κB (NF-κB) in prostate cancer is mediated by protein kinase C epsilon (PKCepsilon).
    Garg R; Blando J; Perez CJ; Wang H; Benavides FJ; Kazanietz MG
    J Biol Chem; 2012 Oct; 287(44):37570-82. PubMed ID: 22955280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of NF-kappaB by oncoproteins and tumor suppressor proteins.
    Madrid LV; Baldwin AS
    Methods Mol Biol; 2003; 223():523-32. PubMed ID: 12777748
    [No Abstract]   [Full Text] [Related]  

  • 37. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.
    Loercher A; Lee TL; Ricker JL; Howard A; Geoghegen J; Chen Z; Sunwoo JB; Sitcheran R; Chuang EY; Mitchell JB; Baldwin AS; Van Waes C
    Cancer Res; 2004 Sep; 64(18):6511-23. PubMed ID: 15374962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NF-kappaB: tumor promoter or suppressor?
    Perkins ND
    Trends Cell Biol; 2004 Feb; 14(2):64-9. PubMed ID: 15102437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma.
    Ferris RL; Grandis JR
    Clin Cancer Res; 2007 Oct; 13(19):5663-4. PubMed ID: 17908953
    [No Abstract]   [Full Text] [Related]  

  • 40. NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues.
    Meteoglu I; Erdogdu IH; Meydan N; Erkus M; Barutca S
    J Exp Clin Cancer Res; 2008 Oct; 27(1):53. PubMed ID: 18928570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.